Show simple item record

dc.contributor.authorNawa Schirwani-Hartl
dc.contributor.authorLena Tschanun
dc.contributor.authorPilar Palmrich
dc.contributor.authorChristina Haberl
dc.contributor.authorNicole Perkmann-Nagele
dc.contributor.authorHerbert Kiss
dc.contributor.authorAngelika Berger
dc.contributor.authorJulia Binder
dc.contributor.otherDepartment of Obstetrics and Gynecology, Division of Obstetrics and Feto-Maternal Medicine, Medical University of Vienna, 1090 Vienna, Austria
dc.contributor.otherDepartment of Obstetrics and Gynecology, Division of Obstetrics and Feto-Maternal Medicine, Medical University of Vienna, 1090 Vienna, Austria
dc.contributor.otherDepartment of Obstetrics and Gynecology, Division of Obstetrics and Feto-Maternal Medicine, Medical University of Vienna, 1090 Vienna, Austria
dc.contributor.otherDepartment of Obstetrics and Gynecology, Division of Obstetrics and Feto-Maternal Medicine, Medical University of Vienna, 1090 Vienna, Austria
dc.contributor.otherDepartment of Laboratory Medicine, Medical University of Vienna, 1090 Vienna, Austria
dc.contributor.otherDepartment of Obstetrics and Gynecology, Division of Obstetrics and Feto-Maternal Medicine, Medical University of Vienna, 1090 Vienna, Austria
dc.contributor.otherDepartment of Pediatrics and Adolescent Medicine, Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Comprehensive Center for Pediatrics, Medical University of Vienna, 1090 Vienna, Austria
dc.contributor.otherDepartment of Obstetrics and Gynecology, Division of Obstetrics and Feto-Maternal Medicine, Medical University of Vienna, 1090 Vienna, Austria
dc.date.accessioned2024-06-26T15:36:07Z
dc.date.accessioned2025-10-08T08:24:05Z
dc.date.available2025-10-08T08:24:05Z
dc.date.issued01-05-2024
dc.identifier.urihttp://digilib.fisipol.ugm.ac.id/repo/handle/15717717/35751
dc.description.abstractInfections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) in pregnancy are associated with the development of preeclampsia and fetal growth restriction (FGR). Recently, preeclampsia was linked to impaired maternal hemodynamic function. This retrospective study evaluated singleton pregnancies with COVID-19 during pregnancy and healthy pregnant controls matched for gestational age from November 2020 to March 2022. Non-invasive assessment of maternal hemodynamics by continuous wave Doppler ultrasound measurements (USCOM-1A<sup>®</sup> Monitor) and oscillometric arterial stiffness (Arteriograph) was performed. Overall, 69 pregnant women were included—23 women after COVID-19 during pregnancy and 46 healthy controls. While two women (8.7%) were admitted to the hospital due to COVID-19-related symptoms, none required intensive care unit admission or non-invasive/invasive ventilation. There were no statistically significant differences in the majority of hemodynamic parameters between the two cohorts. The prevalence of FGR was significantly higher in the COVID-19 during pregnancy group (9.5% vs. healthy controls: 0.0%; <i>p</i> = 0.036), especially in nulliparous women. No difference in angiogenic markers and neonatal outcomes were observed between pregnant women after COVID-19 and healthy controls. In conclusion, no significant differences in hemodynamic parameters or neonatal outcome were observed in women with COVID-19 during pregnancy. However, an increased prevalence of FGR could be described.
dc.language.isoEN
dc.publisherMDPI AG
dc.subject.lccMicrobiology
dc.titleThe Impact of COVID-19 during Pregnancy on Maternal Hemodynamic Function, Angiogenic Markers and Neonatal Outcome
dc.typeArticle
dc.description.keywordsSARS-CoV-2
dc.description.keywordspregnancy
dc.description.keywordsUSCOM
dc.description.keywordsarteriograph
dc.description.keywordssFlt-1/PlGF
dc.description.keywordspreeclampsia
dc.description.doi10.3390/v16060868
dc.title.journalViruses
dc.identifier.e-issn1999-4915
dc.identifier.oaib9fbf4f4099544c5ac779f7cd5e6b99b
dc.journal.infoVolume 16, Issue 6


This item appears in the following Collection(s)

Show simple item record